| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 山西仟源医药集团股份有限公司是以研发、生产和销售抗感染药为主的科技型医药企业.其主要产品有注射用美洛西林钠舒巴坦钠、注射用阿莫西林钠舒巴坦钠、阿莫西林克拉维酸钾片、银杏叶分散片等.2009年公司已跻身全国青霉素市场和半合成青霉素复方制剂市场前十位,在该领域民营内资企业中排名第一.2009年、2010年公司产品注射用美洛西林钠舒巴坦钠、盐酸氨溴索分散片陆续被《健康报》评为"百姓心目中的放心药"和"最受百姓关注的药品"。 | ||||||||||||||||||||||||
| Main Business | 医药、保健食品的研发、生产、销售及医学诊断、基因保存、孕环境检测等医疗健康服务和商业服务。 | ||||||||||||||||||||||||
| Legal Representative | 赵群 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 俞俊贤 | ||||||||||||||||||||||||
| Solicitors | 国浩律师（上海）事务所 | ||||||||||||||||||||||||
| Auditors | 立信中联会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0352-6116426 | ||||||||||||||||||||||||
| Fax No | 0352-6116452 | ||||||||||||||||||||||||
| Website | www.cy-pharm.com | ||||||||||||||||||||||||
| stock@cy-pharm.com;xyy1934@163.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/08/2011 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.104 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.484 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.805B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |